(2024)
Sodium chloride in the tumor microenvironment enhances T cell metabolic fitness and cytotoxicity.
Nat Immunol 25(10),
1830-1844.

Prof. Dr. Gianni Panagiotou
Microbiome Dynamics · Head +49 3641 532-1759 gianni.panagiotou@leibniz-hki.deCurriculum vitae
Main Research Areas
- Microbiome in health and disease
- Systems biology of infections diseases
- Personalized nutrition
Publications
(2024)
Candida albicans translocation through the intestinal epithelial barrier is promoted by fungal zinc acquisition and limited by NFκBmediated barrier protection.
PLOS Pathog 20(3),
e1012031.
(2024)
Exercise-changed gut mycobiome as a potential contributor to metabolic benefits in diabetes prevention: an integrative multi-omics study
Gut Microbes 16(1),
2416928.
(2024)
The gut microbiome, resistome, and mycobiome in preterm newborn infants and mouse pups: lack of lasting effects by antimicrobial therapy or probiotic prophylaxis.
Gut Pathog 16(1),
27.
(2024)
Beneficial microbiome and diet interplay in early-onset colorectal cancer.
EMBO Mol Med 17(1),
9-30.
(2023)
High-throughput profiling of Candida auris isolates reveals clade-specific metabolic differences.
Microbiol Spectr 11(3),
e0049823.
(Review)
(2023)
Human TH17 cells engage gasdermin E pores to release IL-1α on NLRP3 inflammasome activation.
Nat Immunol 24(2),
295-308.
(2023)
Identification of robust and generalizable biomarkers for microbiome-based stratification in lifestyle interventions.
Microbiome 11(1),
178.
(2023)
Gut ecological networks reveal associations between bacteria, exercise and clinical profile in non-alcoholic fatty liver disease patients.
mSystems 8(5),
e0022423.
(2023)
Pathogen-specific innate immune response patterns are distinctly affected by genetic diversity.
Nat Commun 14(1),
3239.